Actuate Therapeutics, Inc. Common stock (ACTU) News & Info.

#ThinkSabio Latest News

Actuate Announces Upcoming Presentation on Initial Data on Elraglusib in Combination with FOLFIRINOX at the AACR Special Conference on Advances in Pancreatic Cancer Research